1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow IIM: new trials by email Literature Review of IIM trials Research Report on IIM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
| AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. Allogeneic NK Cells - Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs) | Phase 2 | Recruiting | Artiva Biotherapeutics, Inc. | 90 | 2025-07-09 | 2026-07-31 |
Arthritis, Rheumatoid (2) · Scleroderma, Systemic (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Multiple Sclerosis (1) · Myositis (1) · Pemphigus (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Scleroderma, Diffuse (1) · Sjogren's Syndrome (1)
Arthritis (2) · Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Rheumatic Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Autoimmune Diseases of the Nervous System (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cardiovascular Diseases (1) · Cytopenia (1)
Artiva Biotherapeutics, Inc. (1) · University Hospital Tuebingen (1)
Germany (2) · Brazil (1) · Bulgaria (1) · France (1) · Italy (1) · Poland (1) · Portugal (1) · Romania (1) · Serbia (1) · Spain (1) · United States (1)
Ann-Christin Pecher (1) · Michael Saddekni, M.D., PgDip, BCMAS (1)